Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Trading Statement

16 Dec 2013 07:00

RNS Number : 5455V
Impellam Group plc
16 December 2013
 



 

 

Impellam Group plc ("Impellam" or the "Company" or "Group")

 

Pre close trading statement

 

Impellam is pleased to announce that trading during the second half of the year reflects the improving economic conditions in the Group's key markets. Our staffing businesses are all expected to see year over year growth in net fees in the second half of the year with both our UK Staffing and US Staffing business seeing full year on year growth.

 

The Group is planning to capitalise on the opportunities available in both the managed services and specialist staffing markets. Both the UK and the US Staffing businesses are keen to accelerate investment in headcount which will lead to upward cost pressure.

 

Whilst we anticipate year on year growth in operating profits in both our UK and US Staffing businesses, the costs associated with both enhanced compliance requirements and the sourcing of medical professionals is still depressing net fee conversion in our Medacs business. Accordingly, Medacs will report year on year operating profit contraction in the second half, albeit at a slower rate than we saw in the first half.

 

The Group's staffing businesses, in total, are therefore expected to see a small year on year decrease in operating profits. However, the outlook is promising with increased activity and recovering markets.

 

Trading in our Carlisle Support Services business has shown some early signs of improvement. Changes to the management structure announced at the half year are starting to deliver the benefits we anticipated in the mobilisation of high volume labour solutions to the retail, transport and logistics sectors. Whilst second half trading will not show any material improvement due to restructure costs, the outlook is more favourable. However, the business has two long term contracts, one a substantial first generation out sourcing agreement, which have proven to be operationally complex, badly priced and financially onerous. In accordance with accounting standards, full provision will be made for the costs of the exiting of one and the future ongoing losses of the other. The total provision, amounting to some £13.0 million, will be taken as an exceptional item. Having carefully reviewed the contracts portfolio, we are satisfied that no other similar contracts exist in the Group.

 

Total Group adjusted operating profit is expected to be about £5.0 million lower than the comparative period last year.

 

During the year, Impellam has returned £19.8 million to shareholders in dividends. The return of cash to shareholders remains a key objective for the Group. A final dividend of 7.0p per share will be recommended. Further details of this will be announced in due course.

 

Enquiries: For further information please contact the appropriate individual below.

 

 

Impellam Group plc

Andrew Wilson

Julia Robertson

Andrew Burchall Tel: 01582 692658

 

 

Cenkos Securities plc

(Nominated Advisor and Broker to Impellam)

Nicholas Wells Tel: 020 7397 8900

Elizabeth Bowman

 

 

Note to Editors:

 

Impellam Group plc conducts business primarily in the UK and North America, with smaller operations in Australia, Ireland, New Zealand and mainland Europe. The Group employs nearly 6,000 people, including 2,500 managers and consultants and more than 3,500 support services workers, across a network of 230 branch and regional offices. The Group operates more than 15 specialty brands across a broad range of staffing sectors which are complemented by businesses in the outsourced support services sector. Impellam Group is ranked 17th on the Staffing Industry Analysts' 2012 Top Global Staffing Companies List.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEXLFFXLFXFBF
Date   Source Headline
30th Jun 20227:00 amRNSTransaction in Own Shares
29th Jun 20224:35 pmRNSResult of Annual General Meeting
29th Jun 20228:57 amRNSForm 8.5 (EPT/RI)
28th Jun 20229:36 amRNSForm 8.5 (EPT/RI)
27th Jun 202210:35 amRNSForm 8.5 (EPT/RI)
23rd Jun 20229:10 amRNSTransaction in Own Shares
23rd Jun 20228:47 amRNSForm 8.5 (EPT/RI)
21st Jun 20223:21 pmRNSForm 8.5 (EPT/RI)
21st Jun 20223:09 pmRNSForm 8.5 (EPT/RI) - amendment
21st Jun 202210:00 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
21st Jun 20227:01 amRNSRule 2.9 Announcement
21st Jun 20227:00 amRNSTransaction in Own Shares
20th Jun 202212:01 pmRNSRule 2.9 Announcement
20th Jun 202212:00 pmRNSTransaction in Own Shares
20th Jun 20229:15 amRNSForm 8.5 (EPT/RI)
17th Jun 20228:46 amRNSForm 8.5 (EPT/RI)
17th Jun 20227:01 amRNSRule 2.9 Announcement
17th Jun 20227:00 amRNSTransaction in Own Shares
16th Jun 20229:37 amRNSForm 8.5 (EPT/RI)
16th Jun 20229:01 amRNSRule 2.9 Announcement
16th Jun 20229:00 amRNSTransaction in Own Shares
15th Jun 20227:11 amRNSForm 8.5 (EPT/RI)
15th Jun 20227:01 amRNSRule 2.9 Announcement
15th Jun 20227:00 amRNSTransaction in Own Shares
14th Jun 202211:42 amRNSForm 8.5 (EPT/RI)
14th Jun 20227:01 amRNSRule 2.9 Announcement
14th Jun 20227:00 amRNSTransaction in Own Shares
9th Jun 20227:02 amRNSForm 8.5 (EPT/RI)
8th Jun 202210:27 amRNSForm 8.5 (EPT/NON-RI)
7th Jun 202212:17 pmRNSForm 8.5 (EPT/RI)
7th Jun 20229:31 amRNSForm 8.5 (EPT/RI)
31st May 20222:04 pmBUSForm 8.3 - IMPELLAM GROUP PLC
25th May 202211:42 amRNSForm 8.5 (EPT/RI)
25th May 202210:16 amRNSRule 2.9 Announcement
25th May 202210:15 amRNSTransaction in Own Shares
24th May 20229:17 amRNSForm 8.5 (EPT/RI)
24th May 20227:01 amRNSRule 2.9 Announcement
24th May 20227:00 amRNSTransaction in Own Shares
20th May 202211:17 amRNSForm 8.5 (EPT/RI)
20th May 20227:01 amRNSRule 2.9 Announcement
20th May 20227:00 amRNSTransaction in Own Shares
19th May 202210:15 amRNSRule 2.9 Announcement
19th May 20229:50 amRNSTransaction in Own Shares
19th May 20227:57 amRNSForm 8.5 (EPT/RI)
12th May 202210:20 amRNSForm 8.5 (EPT/RI)
12th May 20229:51 amRNSRule 2.9 Announcement
12th May 20229:51 amRNSTransaction in Own Shares
11th May 202212:32 pmRNSRule 2.9 Announcement
11th May 202212:30 pmRNSTransaction in Own Shares
11th May 20229:29 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.